
Sign up to save your podcasts
Or


Take our post-test to claim CME credits.
To read a companion newsletter click here.
In her recent newsletter issue (eHIV Review V5 #1), Dr. Ethel Weld, Assistant Professor of Medicine, Pharmacology and Molecular Sciences at the Johns Hopkins School of Medicine, analyzed the current research about the potential uses of two-drug ART regimens. Join her now for a case-based discussion about how that new information can affect patient selection in the clinic.
Hosted on Acast. See acast.com/privacy for more information.
By eHIV Review5
33 ratings
Take our post-test to claim CME credits.
To read a companion newsletter click here.
In her recent newsletter issue (eHIV Review V5 #1), Dr. Ethel Weld, Assistant Professor of Medicine, Pharmacology and Molecular Sciences at the Johns Hopkins School of Medicine, analyzed the current research about the potential uses of two-drug ART regimens. Join her now for a case-based discussion about how that new information can affect patient selection in the clinic.
Hosted on Acast. See acast.com/privacy for more information.